CompletedNot applicableNCT02974049

Lymphatic Filariasis (LF) in Ivory Coast

Studying Filariasis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University Hospitals Cleveland Medical Center
Principal Investigator: Christopher L King, MD PhD
Case Western Reserve University
Intervention: Albendazole(drug)
Enrollment: 189 enrolled
Eligibility: 18-70 years · All sexes
Timeline: 2015 – 2018

Study locations (1)

Cote d'Ivoire, Abidjan, Côte d’Ivoire

Collaborators

Washington University School of Medicine

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02974049 on ClinicalTrials.gov

Other trials for Filariasis

Additional recruiting or active studies for the same condition.

RECRUITINGNCT00001230
Host Response to Infection and Treatment in Filarial Diseases
National Institute of Allergy and Infectious Diseases (NIAID)

See all trials for Filariasis →

← Back to all trials